Mark Vanderveken

Mark Vanderveken specializes in guiding clients through the maze of regulatory compliance and intellectual property, with a keen eye on the life sciences sector. His expertise is vital for companies navigating the complex regulations surrounding the production and sale of regulated products like pharmaceuticals, cosmetics, and medical devices. Mark's strategic advice extends to helping clients safeguard and monetize their intellectual property.

Before his tenure at Fasken, Mark gained valuable experience at a global law firm and further honed his skills during a secondment at a leading pharmaceutical company. He holds a Juris Doctor from the University of Toronto's Faculty of Law, underpinning his robust legal foundation.

Mark's work spans several critical industries, including Agribusiness, Food & Beverage, and Life Sciences, offering tailored solutions in regulatory affairs and intellectual property. His recent involvement includes pivotal transactions such as the public offering for Medexus Pharmaceuticals, Dignio AS's asset acquisition, and Voxtur Analytics' purchase of Municipal Tax Equity Consultants, showcasing his versatility across various sectors.

Notably, Mark played a strategic role in Advanz Pharma's acquisition of Intercept Pharmaceuticals' operations outside the U.S., and Skye Bioscience's merger with Emerald Health Therapeutics. His work with Echelon Wealth Partners and Anjac SAS further exemplifies his skill in navigating complex financial and acquisition deals within the health and beauty sector.

Mark's educational journey includes a Certificate in Transnational Law from the University of Geneva, an MSc in Environmental Physiology, and a BSc in Biology from McMaster University, reflecting his diverse interests and deep understanding of the life sciences.

As a member of prominent legal and regulatory affairs associations, Mark is well-recognized within the legal community for his contributions to the life sciences and regulatory compliance fields. His involvement in professional organizations underscores his commitment to staying at the forefront of legal developments in his areas of expertise.